Samsung Medical Center
Samsung Medical Center
Republic of Korea, Seoul
Keon Hee Yoo
23 years of experience
Clinic is certified :
Aplastic anemia treatment cost in Republic of Korea depends on the therapeutic approach, with a bone marrow biopsy ranging from $700 to $1,500 and bone marrow transplantation costs running from $55,000 to $118,000. Expenses are influenced by the donor type, clinic tier, and patient age. Patients typically find significant savings compared to the US. Top treatment centers are located in Seoul.
Typical Aplastic Anemia Treatment Costs in Republic of Korea
Bookimed Expert Insight: For high-risk cases, multidisciplinary centers like Seoul St. Mary’s Hospital offer world-class success rates. This facility ranks 5th globally for bone marrow transplants. Patients requiring precise diagnostics should consider Seoul National University Hospital for its digitalized safety systems. Samsung Medical Center provides presidential-standard care for complex oncology needs. Allogenic transplants with related donors remain the most cost-effective curative option in Seoul.
| Republic of Korea | Turkey | Austria | |
| Bone marrow transplantation | from $55,000 | from $36,000 | from $140,000 |
| Allogenic bone marrow transplantation from an unrelated donor | from $145,000 | from $80,000 | from $180,000 |
| Allogenic bone marrow transplantation from a related donor | from $75,000 | from $65,000 | from $150,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Aplastic anemia treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Aplastic anemia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Aplastic anemia treatment journey.
The doctor is a leading specialist in the treatment of breast cancer, with extensive training and experience. He completed his training and internship at Yonsei University Medical Center in South Korea and worked as a surgeon at the Yonsei Cancer Center.
From 2011 to 2013, he served as a consultant professor in the breast cancer department at Anderson University in the USA. His research focuses on the treatment of breast cancer using hormonal and chemotherapy drugs.
The doctor is a member of the Korean Medical Association, the American Society of Clinical Oncology, and the American Association for Cancer Research.
The doctor is a pediatrician and hematologist specializing in the treatment of leukemia and aplastic anemia. They are skilled in performing bone marrow transplants for children. The doctor completed their studies at Seoul National University and gained experience as an Assistant Professor in the Department of Pediatrics at Samsung Medical Center. They furthered their expertise as a Research Fellow at Indiana University. Since 2011, they have been contributing to the pediatrics department at Samsung Medical Center.
The doctor is a highly experienced Hematologist-Oncologist with over 26 years of expertise in the field. Specializing in the treatment of colon cancer, hematological oncology, myelomas, and lymphoma, the doctor is proficient in advanced procedures such as Bone Marrow Transplantation, including Alternate Donor and Mismatched Transplants.
With a strong academic background, the doctor holds an M.D. from Yonsei University College of Medicine and a Ph.D. from Sungkyunkwan University College of Medicine. The doctor is also a member of multiple professional societies and has contributed to the field through numerous paper publications.
South Korean medical centers treat severe aplastic anemia with hematopoietic stem cell transplantation (HSCT) and intensive immunosuppressive therapy (IST). Younger patients often receive allogeneic bone marrow transplantation from matched siblings. Older patients or those without donors utilize drug regimens combining antithymocyte globulin with cyclosporine and eltrombopag.
Bookimed Expert Insight: Korea's infrastructure is uniquely suited for complex hematology due to its high-volume digitalized centers. Asan Medical Center alone performs over 65,000 operations annually and maintains a 90% success rate in organ transplants. This volume translates to highly refined protocols for preventing infections during the vulnerable weeks following bone marrow replacement.
Patient Consensus: Patients note it's important to start HLA testing immediately because Korea's donor registry is highly efficient. Many emphasize the need to arrange long-term housing near the hospital for the 3-to-6 month recovery period.
South Korea manages the horse ATG shortage by using rabbit-derived anti-thymocyte globulin as the primary immunosuppressive therapy. Hospitals combine rabbit ATG with cyclosporine and methylprednisolone. Major centers also integrate eltrombopag to improve blood cell counts. Bone marrow transplantation serves as the definitive curative alternative.
Bookimed Expert Insight: Korea's heavy investment in digital infrastructure at centers like Seoul National University Bundang Hospital ensures precise long-term monitoring. Since over 50% of Korean patients require more than one year to respond to rabbit ATG, these digital tracking systems are vital for adjusting therapy. Hospitals like Asan Medical Center, performing over 65,000 surgeries annually, often transition patients to transplant quickly if immunosuppression doesn't show early promise.
Patient Consensus: Patients note it is important to prepare for a longer medical journey than expected. Practical focus often shifts toward finding specialized hematologists in Seoul who can manage the extended follow-up care required for rabbit-based regimens.
Korean medical centers report a 95% 5-year overall survival rate for severe aplastic anemia using bone marrow transplantation. This success rate applies to patients receiving tissue from HLA-identical sibling donors. These outcomes exceed survival rates of 70% typically observed with immunosuppressive therapy protocols.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and holds KOIHA accreditation for safety. This high volume allows for ultra-specialization in complex donor matching and conditioning. Our data shows that centers with these certifications maintain consistency in 5-year survival reporting.
Patient Consensus: Visitors suggest that the administrative speed in Seoul helps reduce wait times for transplant. Many note that clear communication about donor compatibility from the start reduces stress during recovery.
Korean hospitals are highly prepared for international aplastic anemia patients. Major centers like Samsung Medical Center provide dedicated international departments with coordinators and translators. These facilities combine high transplantation volumes with Joint Commission International accreditation to ensure safety for foreign nationals seeking complex hematologic care.
Bookimed Expert Insight: The data shows a powerful link between high patient volume and successful outcomes in Seoul. Asan Medical Center manages over 10,000 daily outpatients and handles nearly half of the nation's transplants. This massive clinical experience often leads to improved protocols and lower rejection rates for complex aplastic anemia cases.
Patient Consensus: Patients highlight that using hospital international desks helps prevent most logistical issues. They also recommend preparing medical record translations early to avoid delays in starting treatment after arrival.
International patients should plan for a 90-day stay in South Korea for a bone marrow transplant. This timeframe covers a 7-day diagnostic phase and 3 to 6 weeks of sterile hospitalization. Patients must remain near the hospital for 60 days of post-discharge monitoring to manage recovery.
Bookimed Expert Insight: While major centers like Asan Medical Center and Samsung Medical Center serve over 2,000,000 patients yearly, their high volume means isolation beds are tightly scheduled. If you miss your conditioning window, you might wait weeks for the next available sterile bed. Always confirm your bed reservation before booking flights, as these facilities maintain nearly 100% occupancy for transplant units.
Patient Consensus: Patients note it is vital to secure housing within 15 minutes of the hospital because post-discharge fatigue makes even short trips difficult. They also suggest planning for a 4 to 6-month stay to account for the slow recovery of the immune system.